These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20196948)

  • 21. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
    Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
    J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine.
    Lin M; Yang LY; Li WY; Peng YP; Zheng JK
    J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dynamic analysis of HBV cccDNA in HepG2 cells infected with Ad-1.2 HBV].
    Liang WF; Liu ZH; Yang J; Luo KX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1374-5. PubMed ID: 17884782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene.
    Günther S; Piwon N; Jung A; Iwanska A; Schmitz H; Will H
    Virology; 2000 Aug; 273(2):286-99. PubMed ID: 10915599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on anti-HBV effects by antisense oligodeoxynucleotides in vitro].
    Liu S; Sun W; Cao Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):338-40. PubMed ID: 11769637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Specific small interfering RNAs inhibit replication of hepatitis B virus].
    Jiao J; Cao H; Zhou MJ; Liu ZH; Ding ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):465-7. PubMed ID: 17545032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
    Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
    Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant.
    Brunelle MN; Saboulard D; Massinet H; Lamant C; Soussan P; Brezillon N; Kremsdorf D
    Antivir Ther; 2010; 15(6):861-9. PubMed ID: 20834098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The replication cycle of hepatitis B virus.
    Urban S; Schulze A; Dandri M; Petersen J
    J Hepatol; 2010 Feb; 52(2):282-4. PubMed ID: 20056291
    [No Abstract]   [Full Text] [Related]  

  • 31. Inhibition of multiple gene expression and virus replication of HBV by stable RNA interference in 2.2.15 cells.
    Ren X; Luo G; Xie Z; Zhou L; Kong X; Xu A
    J Hepatol; 2006 Apr; 44(4):663-70. PubMed ID: 16466826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
    Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
    Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-hepatitis B virus active constituents from Swertia chirayita.
    Zhou NJ; Geng CA; Huang XY; Ma YB; Zhang XM; Wang JL; Chen JJ
    Fitoterapia; 2015 Jan; 100():27-34. PubMed ID: 25447162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
    Wang FS; Zhang JY
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778
    [No Abstract]   [Full Text] [Related]  

  • 35. A Scorpion Defensin BmKDfsin4 Inhibits Hepatitis B Virus Replication in Vitro.
    Zeng Z; Zhang Q; Hong W; Xie Y; Liu Y; Li W; Wu Y; Cao Z
    Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27128943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
    Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
    Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of ciclosporin and tacrolimus on replication of hepatitis B virus in vitro: a comparative study].
    Xia WL; Xie HY; Shen Y; Wu LM; Zhang F; Zheng SS
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):111-5. PubMed ID: 16620716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J; Kist A; Stremmel W; Galle PR
    Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.
    Xie HY; Xia WL; Zhang CC; Wu LM; Ji HF; Cheng Y; Zheng SS
    Acta Pharmacol Sin; 2007 Jul; 28(7):975-84. PubMed ID: 17588333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dynamics of HBV covalently closed circular DNA: amplification and clearance].
    Zhao KK; Miao QL; Miao XH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):794-6. PubMed ID: 19874702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.